Summary Lipo-C is a lipotropic research formulation combining vitamin B6 and B12, widely studied in metabolic and biochemical research for its role in lipid metabolism, energy production, and enzymatic regulation pathways
We have demonstrated the ability to deliver multi-milligram weekly doses of a GLP-1 with a patch, and reach the exposures obesity treatment requires, without an injection or cold storage
A study in July 2024 by researchers at Mass Eye and Ear in Boston found that people taking semaglutide for type 2 diabetes or weight loss had a higher risk of developing nonarteritic anterior ischemic optic neuropathy, an eye condition that can cause blindness, than people taking medications other than GLP-1 drugs for diabetes or obesity
Lysyl oxidase activity is indirectly enhanced through BPC-157's growth factor modulation, producing denser and stronger collagen matrices
Lyophilised powder stored at 20C remains stable for 1224 months
If Novo Nordisk and Eli Lilly and Company are successful in their submissions, semaglutide and tirzepatide products would be deemed too complex or too difficult to compound and would be deemed to pose safety risks to patients if compounded or manufactured incorrectly
